Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
3 Months Ended
Dec. 31, 2020
Dec. 31, 2019
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]    
Net revenues $ 14,616,989 $ 10,578,016
Cost of sales 3,780,356 3,308,921
Gross profit 10,836,633 7,269,095
Operating expenses:    
Research and development 5,677,754 5,299,974
Selling, general and administrative 4,381,880 3,753,514
Total operating expenses 10,059,634 9,053,488
Gain on sale of PREBOOST business 18,410,158  
Operating income (loss) 19,187,157 (1,784,393)
Non-operating expenses:    
Interest expense (1,189,183) (1,141,425)
Increase in fair value of derivative liabilities (604,000) (394,000)
Other expense, net (87,971) (62,026)
Total non-operating expenses (1,881,154) (1,597,451)
Income (loss) before income taxes 17,306,003 (3,381,844)
Income tax expense (benefit) 78,302 (76,743)
Net income (loss) $ 17,227,701 $ (3,305,101)
Net income (loss) per basic common share outstanding $ 0.25 $ (0.05)
Basic weighted average common shares outstanding 70,313,589 65,038,511
Net income (loss) per diluted common share outstanding $ 0.23 $ (0.05)
Diluted weighted average common shares outstanding 75,799,037 65,038,511